Viewing nowCombinationYudapaduo Sustained-Release Tablet 10/500 milligrams
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.

MFDS item code 202300192 · Approved 2023.01.10 · Insurance code 648204670
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to help control blood sugar levels in adults with type 2 diabetes using a combination of dapagliflozin and metformin. It acts as an adjunct to effectively manage blood sugar levels alongside dietary and exercise therapy. For patients whose blood sugar is not adequately controlled and have cardiovascular disease or risk factors, it is necessary to consult a professional regarding the impact of dapagliflozin on the occurrence of cardiovascular events. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is one 5mg/500mg or 10mg/500mg tablet once daily. Titrate the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the patient's current metformin dose or the nearest appropriate therapeutic dose. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and dose adjustments made as appropriate. In patients switching from combination therapy with dapagliflozin and metformin to this medicine, treatment may be initiated at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and dose adjustments made as appropriate. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other glucose-lowering drugs. Because changes may cause variations in blood glucose control, any change in treatment of patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass that resembles a tablet. Renal impairment No dose adjustment is necessary in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2, who have no other symptoms that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR less than 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) decreases to less than 45 mL/min/1.73m2, discontinue this medicine immediately. Renal function should be assessed every 3~6 months. Elderly patients Because metformin is excreted by the kidneys and renal function is more likely to be decreased in elderly patients, this medicine should be used with caution as age increases (see the patient section under '9. Administration to elderly patients' in Precautions for use).
This medication is used for the treatment of type 2 diabetes. It should not be administered to patients with impaired kidney function or acute illnesses. In particular, using this medication in patients with moderate to severe kidney dysfunction may pose risks. Women who are pregnant or breastfeeding should not take this medication. This medication can cause a rare but serious side effect known as lactic acidosis, so if symptoms of lactic acidosis appear, immediate medical attention should be sought. Additionally, caution is needed when taken with insulin or sulfonylureas due to the risk of hypoglycemia. Regular monitoring of kidney function and fluid status is necessary during use, and there may be symptoms of hypotension or dehydration, which should be taken into account. Genital infections and urinary tract infections may occur, so if related symptoms appear, immediate treatment should be sought. Vitamin B12 levels may decrease, so it is advisable to check the vitamin B12 status when taken long-term. Excessive alcohol intake can increase the risk of side effects of this medication, so it should be avoided. If undergoing surgery or imaging tests with contrast agents, it should be discussed with a doctor about temporarily discontinuing this medication. Elderly patients have a higher likelihood of reduced kidney function, so dosage may need to be adjusted and kidney function should be checked frequently. This medication is not used in children as its safety and efficacy have not been established. Possible side effects include dizziness, dry mouth, constipation, and back pain, and if symptoms are severe, consultation with a physician is necessary. There may be dizziness when driving or operating machinery while taking this medication, so caution is advised.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to keep it at room temperature between 1 and 30 degrees Celsius. By storing it this way, the medication’s efficacy is maintained and degradation is prevented.
Pink, double convex, oblong sustained-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YouYoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.